Péterffy Arpád
Debreceni Egyetem, Orvos- és Egészségtudományi Centrum, Altalános Orvostudományi Kar Kardiológiai Intézet, Szívsebészeti Központ Debrecen Debrecen Móricz Zs. krt. 22. 4032.
Orv Hetil. 2007 Jan 7;148(1):5-9. doi: 10.1556/oh.2007.27953.
The author described his results of surgical treatment of mitral valve disease. Of 57 patients, the isolated mitral procedure was performed in 72%, and the combined (valve and coronary) in 28% of the cases. In 75% of the patients valve repair, and in 25% valve replacement were performed. There were 2 cases (3.5%) of early mortality after combined surgery where patients had also ischaemic heart disease. All the replaced valve prostheses and 84% of repaired mitral valve had a normal function. The mitral regurgitation was moderate in 14%, of cases and mild in 2% of cases at the follow up, but no reoperation was needed. After the surgery 85% of patients had sinus rhythm, 13% had atrial arrhythmia and in 2% the pacemaker was needed. Attempt of valve repair had to be made in all patients with mitral valve disease which can be performed in almost every case of degenerative valve prolapse and the rupture of chordae tendineae.
作者描述了他对二尖瓣疾病的外科治疗结果。57例患者中，72%接受了单纯二尖瓣手术，28%接受了联合手术（瓣膜与冠状动脉手术）。75%的患者进行了瓣膜修复，25%的患者进行了瓣膜置换。联合手术后有2例（3.5%）早期死亡病例，这些患者同时患有缺血性心脏病。所有置换的瓣膜假体以及84%修复的二尖瓣功能正常。随访时，14%的病例二尖瓣反流为中度，2%的病例为轻度，但无需再次手术。术后85%的患者为窦性心律，13%有房性心律失常，2%需要起搏器。对于所有二尖瓣疾病患者都必须尝试进行瓣膜修复，几乎在每一例退行性瓣膜脱垂和腱索断裂的病例中都可以进行。
